Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick?

Moderna's market cap has soared on positive results for its mRNA cancer vaccine. Meanwhile, BioNTech has floundered after disappointing clinical results.